LM Funding America Insider Grant: 104,760 Options, $1.26 Strike
Rhea-AI Filing Summary
Form 4 for LM Funding America, Inc. (LMFA) reports an option grant to reporting person Carollinn Gould, who is identified as a director and 10% owner. On 08/27/2025 the reporting person was granted a nonqualified stock option to purchase 104,760 shares of common stock at an exercise price of $1.26 per share. The option expires on 08/27/2035. Per the explanation, the award vests one-half on the 180th day after grant and one-half on the first anniversary of the grant date. The Form is signed by Carollinn Gould on 08/28/2025.
Positive
- Grant disclosed promptly: Form 4 reports the option grant and is signed on 08/28/2025
- Clear vesting schedule: One-half vests at 180 days and one-half at the first anniversary
- Defined option terms: 104,760 options, $1.26 exercise price, expiration 08/27/2035
- Identified reporting person roles: Reporting person is listed as a Director and 10% Owner
Negative
- None.
Insights
TL;DR: A routine director option grant of 104,760 shares at $1.26, standard multi-year vesting and a 10-year term, appears to be a compensation award.
The grant quantity of 104,760 options and the $1.26 exercise price are explicitly reported, with vesting split into two equal tranches: one-half at 180 days and one-half at the first anniversary. The option term extends to 08/27/2035. As filed on Form 4, this is a disclosure of insider compensation rather than an open-market transaction. The filing identifies the reporting person as a director and a 10% owner, which is important for Section 16 reporting obligations.
TL;DR: Director compensation disclosed via option award with time-based vesting; consistent with non-employee director plans.
The explanation states the award was made under the Non-Employee Director Compensation Plan as amended November 18, 2022, and specifies vesting milestones: one-half at 180 days and one-half at the first anniversary. The filing documents compliance with Section 16 reporting by timely disclosing the grant on Form 4 and includes a manual signature dated 08/28/2025. No other governance actions or amendments are disclosed in this form.